4.1 Medications and Exercise Response

4.1 Medications and Exercise Response

ACE Domain I Task 1 Knowledge 8 asks you to know the effects of common medications on physiological responses to exercise, with heart rate and blood pressure named as examples. That knowledge belongs at intake, before the first assessment or loaded set. A client who checks “blood pressure medicine” and then gets an age-predicted target heart rate is already being coached on a number the drug has made unreliable.

A medication list is not a diagnosis, not a prescription, and not a reason to refuse every client who takes a pill. It is a map of how this body is likely to respond when you raise metabolic demand. You use that map to choose intensity tools, hydration rules, cool-down length, and referral triggers. You do not start, stop, skip, split, or titrate any drug.

Why the List Comes Before the Workout

Exercise raises heart rate, systolic blood pressure, ventilation, and muscle blood flow. Many common drugs blunt, exaggerate, or disguise one of those responses. If you only watch the variable the drug has flattened, you can under-dose a fit client or miss a hypotensive or hypoglycemic event. The exam and the gym both punish the same error: treating a medicated heart-rate number as if it were an unmedicated one.

Collect the list on the health-history form, then review it live. Ask for the name, dose, timing (morning, with meals, at bedtime), reason if the client knows it, last dose today, and any recent change. People often remember a brand (“the little white blood-pressure pill”) better than a class. Invite them to bring the bottles, a pharmacy printout, or a phone photo. Include over-the-counter products and supplements: decongestants can raise heart rate and blood pressure; some diet aids do the same; NSAIDs matter when the kidneys and hydration are already stressed.

If the client cannot produce a usable list and wants vigorous work today, hold the vigorous piece. Light movement after a completed PAR-Q+ and ACSM algorithm may still be reasonable; guessing at hidden beta-blockade is not.

A new prescription or a dose change is a re-screen, not a footnote. Document the change, watch the next sessions more closely, and send the client back to the clinician when symptoms appear that the client cannot explain.

Beta-Blockers: The Classic Heart-Rate Trap

Beta-blockers (common names end in -olol: atenolol, metoprolol, propranolol, carvedilol) block catecholamine effects at the heart. Resting heart rate falls. The rise in heart rate during exercise is blunted. Blood pressure usually falls as well. Some clients also feel a lower ceiling on effort because cardiac output cannot climb the usual way.

Do not rely on age-predicted target heart rate (the familiar 220 − age formulas and the percentages built on them). Those equations assume an intact sinus-node response. On a beta-blocker, 70% of a predicted maximum can be a hard interval for one person and an easy walk for another. If a clinician has performed a graded exercise test while the client was taking the usual dose, that medicated maximum is the only heart-rate number that belongs to this person. Most commercial clients do not have that test. For them, RPE (Borg 6–20 or a 0–10 scale you teach consistently) and the talk test are the primary intensity tools.

Watch for fatigue, lightheadedness, and a blood-pressure drop in recovery. A long, easy cool-down still applies. You do not withhold the morning dose “so we can see a real heart rate.” That is a medical decision, and skipping a dose can be unsafe.

Calcium-Channel Blockers

Calcium-channel blockers relax vascular smooth muscle and lower blood pressure. The heart-rate story depends on the subclass. Non-dihydropyridines (verapamil, diltiazem) slow heart rate and reduce contractility, so the same RPE/talk-test rule used for beta-blockers is wise. Dihydropyridines (amlodipine, nifedipine) mainly vasodilate; heart rate may be unchanged or slightly higher from reflex tachycardia. Both subclasses can contribute to post-exercise hypotension. Build a longer cool-down, avoid an abrupt sit-to-stand after hard work, and do not send the client straight into a hot shower or a steam room while still vasodilated.

ACE Inhibitors and ARBs

ACE inhibitors (-pril: lisinopril, enalapril) and angiotensin-receptor blockers (ARBs) (-sartan: losartan, valsartan) lower blood pressure by reducing angiotensin-II–mediated vasoconstriction. Heart rate is usually little changed, so a heart-rate strap is not automatically useless — but blood pressure is. Expect a larger drop in recovery. Some clients report a dry ACE-inhibitor cough; that is a clinician topic, not a cue to diagnose asthma. Extended cool-downs, hydration, and a check for dizziness on standing are the programming implications. You still do not tell the client to skip the morning lisinopril because “we need a higher blood-pressure reading for the chart.”

Diuretics

Diuretics (hydrochlorothiazide, furosemide, chlorthalidone, spironolactone) reduce plasma volume and thereby lower blood pressure. Heart-rate response is usually not the main story. Hydration and electrolytes are. Volume loss plus a warm studio plus a sweating client is a heat-illness and cramp setup. Loop and thiazide diuretics can lower potassium; muscle cramps, premature fatigue, and — rarely — arrhythmia risk rise when electrolytes are off. Potassium-sparing agents change the electrolyte picture rather than eliminating it.

Ask when the dose is taken, whether the client already feels dry or lightheaded by afternoon, and how they handle heat. Program extra fluid breaks, shorten or move outdoor work on hot days, and treat new cramps, confusion, or an unusual racing heartbeat as a stop-and-refer cluster, not as “needs more salt tablets I selected.” You do not add potassium or diuretic-timing advice that contradicts the prescriber.

Statins and Muscle Sensation

Statins (atorvastatin, simvastatin, rosuvastatin) lower LDL cholesterol. They do not systematically blunt heart rate. Their intake flag is muscle. Statin-associated muscle symptoms range from ordinary soreness that tracks a new workload to uncommon true myopathy. You do not diagnose myopathy or rhabdomyolysis. You do notice when soreness is out of proportion to the work, is bilateral and unexplained, comes with dark urine or marked weakness, or appeared after a statin start or dose increase. Document the report, hold aggressive loading if the picture is alarming, and send the client to the prescribing clinician. Telling someone to stop a statin, or dismissing every ache as “just the Lipitor,” both leave scope.

Insulin and Oral Hypoglycemics

Exercise increases muscle glucose uptake and insulin sensitivity. Combined with insulin or insulin-secreting oral agents (sulfonylureas such as glipizide or glyburide), that effect can produce hypoglycemia during the session or hours later. Metformin alone has a much lower hypoglycemia risk; it does not make timing irrelevant if insulin or a secretagogue is also on the list.

Ask what was injected or swallowed, when, and when the last carbohydrate was eaten. Rapid-acting insulin near its peak plus a first hard session is a predictable low. A newly injected limb that you then load heavily can speed absorption — another reason the timing question belongs at intake, not after the client is shaky. Have a rapid carbohydrate source in the room. Learn the client’s usual warning signs (sweat, tremor, confusion, irritability) and whether they have hypoglycemia unawareness. You do not change the insulin dose, skip a shot, or invent an ACE-only glucose cutoff. Industry teaching aligned with ADA and ACSM treats values under about 70 mg/dL as hypoglycemia to treat, often adds carbohydrate before exercise when people on insulin or secretagogues are under about 100 mg/dL, and holds exercise when marked hyperglycemia is paired with ketones. Those are clinician-aligned safety habits, not a license to manage diabetes yourself. Unexplained lows, new foot ulcers, or a client who has never been taught to check glucose go back to the diabetes care team.

Bronchodilators and Antidepressants

Bronchodilators, especially short-acting beta-agonists such as albuterol, can raise heart rate and cause tremor. They also make exercise possible for many people with asthma or exercise-induced bronchoconstriction. Intake questions: Is this a rescue inhaler, a daily controller, or both? Is the inhaler present today? How often is rescue used? Frequent rescue use means the airway disease is not controlled — that is a referral, not a harder warm-up. Do not train through wheezing, chest tightness, or a rescue dose that is not helping. A longer warm-up is reasonable once medical control is in place; it is not a substitute for the inhaler.

Antidepressants vary. Tricyclics (amitriptyline) more often raise resting heart rate and cause orthostatic hypotension. Many SSRIs and SNRIs have smaller heart-rate effects but can still contribute to dizziness, sleep change, or — with some agents — altered sweating and heat tolerance. None of that authorizes you to recommend stopping the drug “because it might blunt fat loss” or “because we need a cleaner heart-rate file.” Ask about dizziness on standing, recent dose changes, and whether the prescriber already limited certain activities. Coordinate, do not substitute.

Class, Expected Effect, Programming Implication

Intensity Tools When Heart Rate Lies

Teach the client one RPE scale on day one and use the same anchors every session. Pair it with the talk test: comfortable speech tracks moderate work; broken speech tracks vigorous work. On a beta-blocker, a client who cannot finish a sentence may already be above the intended zone even if the watch reads 110. Record both RPE and heart rate so you can see the relationship over weeks; do not throw the strap away, and do not let the strap overrule symptoms.

Scope line: you interpret the exercise response. The prescriber interprets the drug. If the response is unsafe — near-syncope, unexplained tachycardia, wheezing that does not reverse, a suspected hypoglycemic event that the client cannot self-treat, or muscle pain with dark urine — you stop, document, and refer. You never “fix” the chart by changing the medicine.